Tag: neurological disorders
EMVision’s neuroimaging advancements fueled by $15.28M from Keysight Technologies
EMVision Medical Devices Limited announced a strategic AUD 15.28 million investment from Keysight Technologies Inc, to bolster the former's neuroimaging technology and its potential to revolutionise diagnosis and treatment outcomes for neurological disorders.
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
